News from the FDA/CDC
News from the FDA/CDC
Fewer people having problems with medical bills
The number of people under age 65 years who were in families having trouble paying medical bills dropped by more than 22% from 2011 to 2016,...
News from the FDA/CDC
FDA bans powdered gloves
The FDA has banned powdered gloves for use in health care settings, citing “numerous risks to patients and health care workers.”
News from the FDA/CDC
XR version of Synjardy gets FDA’s nod
The extended-release version of empagliflozin coupled with metformin in a once-daily tablet has received FDA approval for use in glucose control...
News from the FDA/CDC
Empagliflozin first antidiabetes drug to gain cardioprotective indication
Empagliflozin is the first antidiabetes medication to be approved for reducing the risk of cardiovascular death in patients with type 2 diabetes...
Article
FDA reaffirms rivaroxaban’s atrial fib efficacy in ROCKET AF
The Food and Drug Administration reaffirmed its confidence in the data supporting the claim that rivaroxaban (Xarelto) is a safe and effective...
News from the FDA/CDC
Four of five health care providers get flu shot
Physicians had the highest level of coverage (95.6%), while health care assistants and aides had the lowest (64.5%).
News from the FDA/CDC
FDA approves first-in-class oral antiplatelet drug vorapaxar
The novel antiplatelet drug vorapaxar has been approved for reducing the risk of myocardial infarction, stroke, cardiovascular death, and need for...